HPC Offered for PRESERVE Expansion
About this study
Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow product
- Condition
- Bone Marrow Transplant (BMT)
- Tested
- Bone Marrow Transplant with Ossium's HPC, Marrow (bone marrow recovered from deceased organ and tissue donors)
- Sponsor
- Ossium Health, Inc.
Who can join
- Age
- 12 to 80 years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 5
- Minimum age: 12 years
- Maximum age: 80 years
- Study condition: Bone Marrow Transplant (BMT)
- Patients aged 12-80 may be eligible\* to receive bone marrow for transplantation through the Ossium HOPE Program if:
- Their treating physician determined they are eligible for allogeneic bone marrow transplant Their treating physician determined that the potential benefit outweighs the potential risks
Where
4 sites, 4 recruiting
University of Alabama, Birmingham
Birmingham, Alabama, United States
The Ohio State University Medical Center
Columbus, Ohio, United States
Henry Ford Health
Detroit, Michigan, United States
Tristar Centennial Medical Center
Nashville, Tennessee, United States
Contact
-
Preethi Prasad, Senior Director Clinical Operations
415-513-5535 preethi.prasad@ossiumhealth.com
Potential match only. Final eligibility is determined by the study team.